Metformin in Diabetic Patients Undergoing Coronary Angiography

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT04766008

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Humanitas Hospital, Italy (from the registry)
Registry
  • NCT NCT04766008
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04766008. Allocation not applicable; no masking; primary purpose prevention. Start 2020-01-15 (actual); primary completion 2022-04-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metformin in Diabetic Patients Undergoing Coronary Angiography
Acronym
NO-STOP
Condition
Diabetes Mellitus
Condition
Lactic Acidosis With Diabetes Mellitus
Condition
Contrast-induced Nephropathy
Condition
Metformin Associated Lactic Acidosis
Intervention (Drug)
Metformin
Lead sponsor
Humanitas Hospital, Italy (class: other)

Record details

Record id
cardio:ct-nct04766008
Content hash
c9d8d53ccc59ba201d04c02fcf934e20699523df96ffb74763ff0e90eaf4c34d